Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

ABBOTT INDIA LTD. - 500488 - Unaudited Financial Results Of The Company For The Second Quarter And Half Year Ended On September 30, 2021

 Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose a text of Unaudited Financial Results of the Company for the second quarter and half year ended on September 30, 2021, approved by the Board of Directors at its Meeting held today i.e., Friday, November 12, 2021 along with the Limited Review Report issued by S R B C & CO. LLP, Statutory Auditors of the Company. The Meeting of the Board of Directors of the Company commenced at 10.00 am and concluded at 12.10 pm.
12-11-2021
Bigul

ABBOTT INDIA LTD. - 500488 - Board Meeting Intimation for Approving The Text Of Unaudited Financial Results Of The Company For The Second Quarter And Half Year Ended On September 30, 2021.

 ABBOTT INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2021 ,inter alia, to consider and approve the text of Unaudited Financial Results of the Company for the second quarter and half year ended on September 30, 2021. Further please note that in terms of Abbott India Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders and in accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) (Amendment) Regulations, 2019, the Trading Window of the Company remains closed from Thursday, September 30, 2021 to Sunday, November 14, 2021 (both days inclusive).
02-11-2021
Bigul

Abbott India Ltd - 500488 - Statement Of Investor Complaints For The Quarter Ended September 2021

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 1670 Name of the Signatory :- Krupa AnandparaDesignation :- Company Secretary and Compliance Officer
11-10-2021
Bigul

Abbott India Ltd - 500488 - Shareholding for the Period Ended September 30, 2021

 Abbott India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here
11-10-2021
Bigul

Abbott India Ltd - 500488 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 In terms of Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, please find enclosed, Certificate issued by KFin Technologies Private Limited, Registrar and Share Agent of the Company for the second quarter ended September 30, 2021. Kindly acknowledge receipt of the same.
06-10-2021
Bigul

ABBOTT INDIA LTD. - 500488 - Closure of Trading Window

 This is to inform you that, in accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in the Shares of the Company by the Designated Persons and their immediate relatives shall be closed from tomorrow i.e. Thursday, September 30, 2021 and the same shall reopen after 48 hours from the declaration of Unaudited Financial Results of the Company for the second quarter ended on September 30, 2021. You are requested to take the same on record.
29-09-2021

Strong growth rates expected to drive Abbott India's outperformance

 New launches, power brands, digital initiatives to keep it ahead of peers
15-09-2021

Trade Spotlight: What should investors do with Abbott India, KPR Mill and Apollo Pipes?

 Here's what Shrikant Chouhan of Kotak Securities recommends investors should do with these stocks when the market resumes trading today.
13-09-2021
Bigul

Movers and Shakers: Stocks that will see action this week

 Abbott India (20,698.9)Records new highThe stock of Abbott India climbed 3.5 per cent with above-average volume, breaking above a key short-term resis
11-09-2021

Abbott India's outlook brightens with a rebound in pharma market

 Multinational companies with a focus on India have remained insulated from the volatility seen in other markets
03-09-2021
Next Page
Close

Let's Open Free Demat Account